PDCD1 and Hodgkins lymphoma: Reports have mentioned the presence of PD-1+ NK cells in ovarian carcinoma, Hodgkin lymphoma, intestinal adenocarcinoma, Kaposi sarcoma, bladder carcinoma, lung, breast, and uterine cancer patients [28,39].